Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Oncology Research and Treatment|April 30, 2018
Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from HypeMarkus Moehler
Current Oncology (Toronto, Ont.)|March 24, 2022
Immunotherapy in Gastric CancerAnica Högner, Markus Moehler
Current Opinion in Oncology|May 5, 2009
Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new eraAnna D Wagner, Markus Moehler
JAMA Oncology|September 4, 2020
Pembrolizumab in First-line Gastric Cancer: Win, Lose, or Draw?Elizabeth C Smyth, Markus Moehler
Therapeutic Advances in Medical Oncology|September 7, 2019
Late-line treatment in metastatic gastric cancer: today and tomorrowElizabeth C Smyth, Markus Moehler
Oncology Research and Treatment|April 30, 2018
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative StrategiesMaria Alsina, Markus Moehler, Sylvie Lorenzen
Innovative Surgical Sciences|March 27, 2025
Immunotherapy as a new perspective for the therapy of esophageal cancerYvonne Huber, Markus Moehler, Anica Högner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 4, 2005
New chemotherapeutic strategies in colorectal cancerMarkus Moehler, Andreas Teufel, Peter R Galle
Oncology Research and Treatment|April 30, 2018
Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative StrategiesMarkus Moehler, Katrin Göpfert, Heinz-Josef Lenz
World Journal of Gastroenterology|August 23, 2008
Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumorsCarl C Schimanski, Peter R Galle, Markus Moehler
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Oncology Research and Treatment|April 30, 2018
Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from HypeMarkus Moehler
Current Oncology (Toronto, Ont.)|March 24, 2022
Immunotherapy in Gastric CancerAnica Högner, Markus Moehler
Current Opinion in Oncology|May 5, 2009
Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new eraAnna D Wagner, Markus Moehler
JAMA Oncology|September 4, 2020
Pembrolizumab in First-line Gastric Cancer: Win, Lose, or Draw?Elizabeth C Smyth, Markus Moehler
Therapeutic Advances in Medical Oncology|September 7, 2019
Late-line treatment in metastatic gastric cancer: today and tomorrowElizabeth C Smyth, Markus Moehler
Oncology Research and Treatment|April 30, 2018
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative StrategiesMaria Alsina, Markus Moehler, Sylvie Lorenzen
Innovative Surgical Sciences|March 27, 2025
Immunotherapy as a new perspective for the therapy of esophageal cancerYvonne Huber, Markus Moehler, Anica Högner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 4, 2005
New chemotherapeutic strategies in colorectal cancerMarkus Moehler, Andreas Teufel, Peter R Galle
Oncology Research and Treatment|April 30, 2018
Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative StrategiesMarkus Moehler, Katrin Göpfert, Heinz-Josef Lenz
World Journal of Gastroenterology|August 23, 2008
Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumorsCarl C Schimanski, Peter R Galle, Markus Moehler
Pageof 22